Table 3.
Proportion of variance explained (Equation (7)) for each component, estimated by BIDIFAC using the breast cancer data. The parentheses denote the rank of the estimated components.
Global | Global+Row | Global+Col | Global+Row+Col | Signal | |
---|---|---|---|---|---|
Tumor mRNA | 0.14 (34) | 0.32 (68) | 0.45 (93) | 0.58 (127) | 0.67 (173) |
NAT mRNA | 0.23 (34) | 0.50 (68) | 0.44 (4l) | 0.66 (75) | 0.78 (83) |
Tumor miRNA | 0.09 (34) | 0.46 (67) | 0.30 (93) | 0.63 (126) | 0.76 (175) |
NAT miRNA | 0.13 (34) | 0.66 (67) | 0.24 (4l) | 0.75 (74) | 0.76 (79) |